NUP98 and acute myeloid leukemia: Approximately 4–7% of pediatric patients with AML have disease characterized by (or driven by) NUP98 rearrangements (NUP98-r AML) (Fig. 1C); it is most common in male patients who are not infants (median age, 11.8 years) [60–62].